Novavax Reports Q3 Loss, Misses Revenue Estimates

Nasdaq2021-11-05

Novavax (NVAX) came out with a quarterly loss of $4.31 per share versus the Zacks Consensus Estimate of a loss of $4.04. This compares to loss of $3.21 per share a year ago. These figures are adjusted...

网页链接
免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

  • MHh
    2021-11-05
    MHh
    Because of all the delays? Means Q4 might be better? Especially with now many countries are advising for booster shots. But that would depend if the advisories allow for non-mRNA vaccines if the previous course was mRNA- based
  • Galaxy88
    2021-11-05
    Galaxy88
    Looking for some good news to move up 
  • HeroSmurf
    2021-11-05
    HeroSmurf
    Gg
  • KeeBoonTong
    2021-11-05
    KeeBoonTong
    Lalalala
  • BBBSIN
    2021-11-05
    BBBSIN
    HUAT ah! 
  • BabySim
    2021-11-05
    BabySim
    Ok
发表看法
13